Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06515925 · ClinicalTrials.gov registry record · NA
Our Whole Lives Gemini: Virtual Integrative Medical Group Visits for Managing Chronic Pain
A NA study of Chronic Pain, sponsored by Cambridge Health Alliance.
- Recruiting
- Registry status
- NA
- Development phase
- 212
- Enrollment target
- 1
- Study location
NCT06515925: Recruiting NA study of Chronic Pain, sponsored by Cambridge Health Alliance.
NCT06515925 is a NA study of Chronic Pain that is actively recruiting participants, run by Cambridge Health Alliance. The registered enrollment target is 212 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06515925, a NA study of Chronic Pain, is actively recruiting participants, sponsored by Cambridge Health Alliance.
- RECRUITING
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to test the efficacy of a non-prescription medicine, web-based platform solution for patients with chronic pain, to improve pain self-management and related outcomes. The main question investigators aim to answer is; would the use of this web-based intervention plus an online group visit compared to control result in better pain-related outcomes and improved pain impact?
Primary Outcome
The primary trial aim is to reduce pain impact.
Conditions Studied
Interventions
- BEHAVIORAL Our Whole Lives (OWL)
- BEHAVIORAL Low Dose Mindfulness Training
Study Locations (1)
Massachusetts
- Cambridge Health Alliance Center for Mindfulness and Compassion - Malden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What NCT06515925 shows while recruiting
NCT06515925 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Our Whole Lives (OWL) is the first listed.
NCT06515925 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06515925 about?
NCT06515925 is a clinical study titled "Our Whole Lives Gemini: Virtual Integrative Medical Group Visits for Managing Chronic Pain". The goal of this research study is to test the efficacy of a non-prescription medicine, web-based platform solution for patients with chronic pain, to improve pain self-management and related outcomes. The main question investigators aim to answer is; would the use of this web-based intervention plu...
What is the current status of trial NCT06515925?
This trial is currently recruiting. It is a NA study. The enrollment target is 212 participants. The study started on 2024-08-01. Estimated completion is 2025-11-30.
What conditions does trial NCT06515925 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT06515925?
The interventions under investigation include: Our Whole Lives (OWL) (BEHAVIORAL), Low Dose Mindfulness Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06515925?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06515925 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06515925's enrollment target sits among peer trials
212 79th of 301 higher than 223 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI